Reviews/Added Sugar and Metabolic Health/Sugar raises triglycerides
Cardiometabolic · ASMH-CMB-01 · v2
Borderline: within 4 points of the Likely/Uncertain boundary, so a re-grade could land either side.
The question is whether eating a lot of added sugar pushes up the fat called triglyceride in the blood. The strongest direct human trial here found that sugary drinks raised triglyceride after meals, and the more sugar people drank the bigger the rise [2], while a month of table sugar kept triglyceride elevated in a crossover trial [7]. But the picture is mixed: when sugar was swapped in without adding extra calories [8], and in trials lasting ten weeks to a year [3][4], triglyceride did not change, and a large population study linked sugar to other blood-fat problems rather than triglyceride [13]. A mechanism study showed the liver making more new fat on sugar but not releasing more triglyceride into the blood [1]. So the effect looks real but concentrated in the after-meal state and when sugar adds extra calories, rather than a guaranteed rise in everyone. That split is why the panel supported the direction without treating it as settled.
The most direct human support is [2], a dose-response intervention in which HFCS beverages at 10%, 17.5% and 25% of energy requirements produced significant linear increases in postprandial triglyceride (0%: 0 ± 4; 10%: 22 ± 8; 17.5%: 25 ± 5; 25%: 37 ± 5 mg/dL, P < 0.0001), and [7], where serum triglyceride remained elevated at 4 weeks during sucrose but not honey. Mechanistically [1] found fructose- and sucrose-sweetened beverages roughly doubled basal hepatic fractional secretion of newly synthesised fatty acid versus control at stable caloric intake. Against this, [8] (eucaloric, 10 weeks) and [4] (60 days) reported no change in triglycerides, and [3] (12 months) found the triglyceride-to-HDL ratio unchanged between beverage groups. Observational data [13] tied >20 g/d free sugar to 38% higher dyslipidemia risk (HR = 1.38, 95% CI: 1.04-1.84) but located the significant subtypes in hypo-HDL and hyper-LDL, not triglyceride. The contested point: The division is whether the triglyceride rise is a general effect or one confined to the postprandial state and to hypercaloric or high-dose exposure. The clearest positive result [2] is postprandial triglyceride obtained by adding sugar on top of energy requirements, while the eucaloric substitution [8] and the long-duration RCT [3] show no fasting-triglyceride effect.
All 13 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Added Sugar and Metabolic Health, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The strongest positive result [2] is postprandial triglyceride, obtained by adding HFCS on top of energy requirements, confounding added sugar with excess calories; the eucaloric substitution design [8] isolates sugar and finds no TG change, so part of any effect is caloric, not sugar-specific.
The claim says 'serum triglycerides' without qualification, but the clearest effect is postprandial, while fasting-TG effects are inconsistent across the corpus — an indirectness/scope overreach.
Where it remains uncertain. Eucaloric substitution [8], a 12-month RCT [3], and a mechanism study with unchanged VLDL-triglyceride secretion [1] show no effect, and population data locate the signal in HDL and LDL [13].
Aleatory
Supportive trials are small (e.g. 37 subjects in [7]) so between-person variation in lipid response adds noise to any mean effect.
The load-bearing papers from a corpus of 13, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Mechanistic nuance: added sugar raised de novo lipogenesis but not basal VLDL-TG secretion, weakening a clean causal path to serum TG.
“Fructose intake did not change basal secretion of newly synthesized VLDL-triglyceride, nor did it alter rates of peripheral lipolysis”
Panel auditInternal validity: medium · scope of inference: Hepatic fatty-acid and VLDL-TG synthesis in healthy lean men consuming moderate-dose sugar beverages for 7 weeks.Key limitations: serum TG concentration not reported · surrogate synthesis endpoint · healthy lean men only
Strongest direct support: dose-dependent rise in postprandial triglyceride with HFCS intake.
“significant linear dose-response increases of lipid/lipoprotein risk factors for CVD and uric acid: postprandial triglyceride (0%: 0 ± 4; 10%: 22 ± 8; 17.5%: 25 ± 5: 25%: 37 ± 5 mg/dL, mean of Δ ± SE, P < 0.0001 effect of HFCS-dose)”
Panel auditInternal validity: medium · scope of inference: Postprandial triglyceride response to 2 weeks of HFCS-sweetened beverages in adults aged 18-40 with BMI 18-35.Key limitations: nonrandomized assignment · postprandial rather than fasting TG · 2-week duration
Counter-evidence: 12-month RCT found no effect of sugar-sweetened beverages on the serum TG:HDL ratio.
“Change in serum triglyceride to high-density lipoprotein cholesterol ratio was not different between groups.”
Panel auditInternal validity: high · scope of inference: Adults who habitually consumed SSBs, over 12 months of beverage replacement.Key limitations: composite TG:HDL ratio not TG alone · replacement design not pure added-sugar contrast
The abstract reports sugar associations with remnant cholesterol and non-HDL-C (and fruit juice with LDL-C) but gives no triglyceride-specific result.
Panel auditInternal validity: low · scope of inference: Perimenopausal Latvian women with moderately high LDL-C.Key limitations: no sugar-TG association reported · cross-sectional self-report diet · small sample
4 of 13 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
Direction is carried by the strongest direct and mechanistic evidence, but caloric-context confounding, the postprandial-versus-fasting distinction, and null long-term RCTs keep it below Established.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Eucaloric, long-duration fasting-TG trial. Separates the sugar-specific effect from added calories over a durable window, the exact gap left by the null eucaloric [8] and the ratio-outcome [3]. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A randomized controlled feeding trial substituting added sugar for other carbohydrate at constant energy, with fasting serum triglyceride as the primary outcome over 6-12 months.
Open question: Does added sugar raise fasting serum triglyceride when substituted for other carbohydrate at constant calories? Why it is still open: The only eucaloric trial [8] reported no change, while positive trials [2] added sugar on top of energy requirements.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19